Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on CN121085785A. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN121085785A reveals ferrocene-based ligands for asymmetric allylic substitution, offering high enantioselectivity and cost reduction in pharmaceutical intermediate manufacturing.